
Progressive Aerobic Exercise May Help Improve Cognitively Impaired Patients With MS
No cognitive improvements were observed for exercise versus waitlist groups of cognitively normal patients with MS.
A recent randomized controlled trial (RCT) investigated progressive
No changes in Brief Repeatable Battery of Neuropsychological (BRB-N) test scores were seen in either the “exercise” or “waitlist” groups after PAE. When comparing cognitively impaired patients (43% of all patients, n = 37) between the 2 groups, there was a potential clinically relevant improvement in the symbol digit modalities test (SDMT).
Principal author Martin Langeskov-Christensen, PhD, researcher, Aarhus University, and colleagues wrote that “this is the first study to investigate cognitive performance outcomes in patients with MS in a longitudinal RCT following 24 weeks of supervised high-intensity PAE intervention... the potential effects of PAE were analyzed in both the total group and in the subgroup showing mild to moderate cognitive impairment, using a validated battery of neuropsychological tests.”
A total of 86 patients enrolled in the study and were randomized to either the exercise group (n = 43) or the waitlist control group (n = 43). Relapsing-remitting MS (RRMS) was the most common disease type, with 75 patients (87.2%) with enrolled. Based on a deviation in Z-scores from published reference BRB-N test scores, 37 patients (43%) were classified as cognitively impaired, 22 in the PAE group and 15 in the waitlist group. The exercise group underwent 24 weeks of supervised PAE followed by self-guided physical activity. The waitlist group underwent 24 weeks of their habitual lifestyles, followed by supervised PAE.
READ MORE:
Cardiovascular fitness (VO2-max) increased between groups by 3.5 mL O2/min/kg (95% CI; 2.0–5.1; P <.01) in the exercise group vs the waitlist group. Around half of the overall planned exercise sessions were completed: 44.8 (standard deviation [SD], 2.6) of the planned 93.3 (SD, 5.4) sessions. In the exercise group, 12 patients were unable to adhere to the highest prescribed intensity (90% to 95% of max heart rate [HRmax]) of the last 8 weeks of PAE, and the mean intensity of these 12 patients was 87.8% HRmax.
After 24 weeks, 13 patients (15.1%) had dropped out of the study, 7 from the PAE group and 6 from the waitlist. There were 9 (25.6%) additional dropouts from 24 to 48 weeks. The PAE intervention was well-tolerated and no serious adverse events occurred. After 48 weeks, the improvements in cardiovascular fitness seen in the exercise group disappeared (post-24 weeks of self-guided physical activity following the supervised PAE).
No cognitive improvement changes were observed between the groups after 24 weeks, but improvements in Z-scores were seen after 48 weeks in the initial exercise group. Long-term retrieval improved by 5.3 (95% CI. 2.0–8.6; P <.01), consistent long-term retrieval improved by 5.6 (95% CI. 1.1–10.1; P =.01), delayed recall in the selective reminding test (SRT) improved by 0.6 (95% CI. 0.1–1.1; P =.02), and verbal domain scores in the SRT improved by 0.4 (95% CI. 0.1–0.6; P <.01). Total BRB-N Z-scores improved by 0.2 (95% CI. 0.0–0.4; P =.02). The major depression inventory score increased by 2.4 (95% CI. 0.5–4.2; P =.01) as an indicator of worsened mood.
Improvements at the 24- and 48-week mark were seen in the cognitively impaired subgroup of the exercise group (n = 22). Symbol digital modalities test (SDMT) scores, indicative of processing speed, increased by 4.9 (95% CI. 1.3–11.1; P <.01). Long-term retrieval improved by 6.8 (95% CI. 3.0–10.6; P <.01), consistent long-term retrieval improved by 7.4 (95% CI. 0.9–13.8; P =.03), delayed recall in the SRT improved by 1.2 (95% CI. 0.2–2.2; P =.02), and verbal domain scores in the SRT improved by 0.5 (95% CI. 0.2–0.9; P <.01).
“These results suggest no direct effect of PAE on cognitive performance in a representative group of patients with MS, whereas a potential clinical relevant improvement in processing speed was observed in a subgroup comprising cognitively impaired patients with MS... further adequately powered long-term and large-scale exercise studies, including well-defined cognitively impaired patients with MS and a validated battery of neuropsychological tests are warranted, since treatments specific for cognitive impairment in MS are highly needed,” Langeskov-Christensen and colleagues concluded.
REFERENCE
Langeskov-Christensen M, Hvid LG, Jensen HB, et al. Efficacy of high-intensity aerobic exercise on cognitive performance in people with multiple sclerosis: A randomized controlled trial. Mult Scler. Published online November 24, 2020. doi:10.1177/1352458520973619
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.